IEQ Capital’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

IEQ Capital’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-50,000	Closed	-$90.5K	–	977
2023 Q2	$90.5K	Sell	50,000 -56,672	-53%	-$104K	﹤0.01%	858
2023 Q1	$141K	Hold	106,672	–	–	﹤0.01%	838
2022 Q4	$180K	Buy	106,672 +50,000	+88%	+$63.3K	0.01%	746
2022 Q3	$105K	Buy	+56,672	New	+$169K	﹤0.01%	800

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IEQ Capital's PRDS Position: Q3 2023 in Review

IEQ Capital sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 50,000 shares — an estimated $90.5K sold.

IEQ Capital first reported a position in PRDS in Q3 2022 and held it in 4 quarters. The position peaked at $180K in Q4 2022. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

IEQ Capital reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
IEQ Capital sold 50,000 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $90.5K.
IEQ Capital first reported a position in Pardes Biosciences, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
IEQ Capital's Pardes Biosciences, Inc. Common Stock position peaked at $180K in Q4 2022.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on IEQ Capital's 13F filing for Q3 2023, filed 6 Nov 2023.